🌿 Industry
DEA registration pushback reaches operators across multiple states. Marijuana Moment reports show-cause orders sent to at least some businesses in California, Delaware, Illinois, North Dakota, Oregon and Washington, D.C., in addition to the previously reported Minnesota case. — Marijuana Moment
DEA cites mixed medical/adult-use licensing and patient-certification requirements. The practical issue is whether an operator’s license, patient documentation and supply chain satisfy the federal medical framework
Pennsylvania’s incoming Senate leader says legalization is not an immediate priority. Jay Costa said lawmakers would discuss adult-use cannabis in the coming months, but not necessarily right away. — Marijuana Moment
Democratic control of the legislature does not establish a timetable for legalization. Gov. Josh Shapiro’s stated post-election priorities have focused on wages, housing and abortion rights
Sixteen governors renew the push for SAFE Banking. The governors urged congressional leaders to pass protections for financial institutions serving state-legal cannabis businesses and their service providers. — ABA Banking Journal
Massachusetts voters reject repeal of adult-use cannabis. Question 8 was defeated, preserving MA’s regulated adult-use market. — Cannabis Business Times
Preliminary results reported by AP showed roughly 76% voting no and 24% yes
Colorado’s supply shakeout is not yet a market recovery. Reklaim’s updated market review argues that cultivation exits may be tightening flower supply even as retail demand remains weak. — Reklaim

Wiz Khalifa will keynote and perform at MJBizCon on December 2. The Khalifa Kush co-founder will discuss building a cannabis brand before performing at the Las Vegas Convention Center.
💵 Deals

Organigram agrees to acquire Aurora for C$561M, backed by BAT. The definitive agreement values Aurora at C$7.80 per share on a fully diluted equity-value basis. Holders may elect cash, shares or a mix, subject to proration—not an unrestricted all-cash exit for everyone. BAT committed C$187.5M, and ATB committed up to C$210M of senior facilities. Management identifies more than C$50M in synergies. Closing is expected in January 2027, subject to shareholder, court and regulatory approvals. A November 13 material-change filing details a C$25.2M Aurora termination fee in specified circumstances and Organigram matching rights of at least five business days for a superior proposal.
Vireo closes FLUENT and expands its Florida platform. The November 9 closing adds 33 dispensaries and ~117,000 sq. ft. of cultivation and production capacity. Vireo says the combined Florida platform has ~74 operational dispensaries. The closing followed FLUENT’s debt-to-equity conversion. Vireo issued ~6.15M shares; FLUENT converted ~$35.7M of senior debt to equity immediately before closing.
📄 Company Updates / Earnings
Curaleaf grows both domestically and internationally, while margins compress. Q3 revenue increased 10.9% to $352.7M, including $59M internationally. Adjusted EBITDA was $77.6M at a 22.0% margin, down 56 basis points YoY. Operating cash flow from continuing operations was ~$22M; management continues to target ~$150M for the full year. Net loss from continuing operations was ($37.4M).
GTI’s normalized EBITDA needs a licensing-fee caveat. Q3 revenue increased 11.3% to $324.4M, with $58.3M of operating cash flow and $316M of cash. Normalized EBITDA was $89.4M, but includes a $15.75M add-back for RYTHM license fees. Adjusted EBITDA before that add-back was $73.7M vs. $80.2M a year earlier.
Trulieve generates $45M of quarterly FCF on its medical-only perimeter. Q3 reported revenue was $230.2M, with 64% gross margin, $89M adjusted EBITDA and $74M operating cash flow. FCF was $45M and cash ended at $327M. The 20% reported YoY revenue decline is not a like-for-like operating decline: the comparison is affected by Harvest’s deconsolidation. The medical-only perimeter changes the revenue and margin comparison with the prior year.
Verano grows sales and operating cash flow, but adjusted EBITDA declines. Q3 revenue rose 5% to $212.4M. Adjusted EBITDA was $50.4M, down from $53.1M, with margin declining to 24% from 26%. Operating cash flow increased to $49M from $26M; after $13M of capital spending. Net loss narrowed to ($4.1M) from ($43.8M), helped by lower tax expense. Cash finished at $102.1M, and full-year CapEx guidance increased to $54M–$60M.
Cresco grows sales, but adjusted EBITDA falls. Q3 revenue rose ~5% to $172.8M. Adjusted EBITDA declined to $34.9M from $39.8M, with margin down to 20.2% from 24.1%. Operating cash flow was ~$26M and FCF was ~$21M.
TerrAscend extends its positive-cash-flow streak. Q3 revenue increased 4.8% to $68.2M and adjusted EBITDA reached $17.5M. Operating cash flow from continuing operations was $8.8M and FCF was $6.1M, marking the 17th and 13th consecutive positive quarters, respectively.
Vireo’s acquisition-led growth takes reported quarterly revenue above $250M. Q3 GAAP revenue rose 177% to $253.7M, including $55.6M of non-cannabis revenue. Adjusted EBITDA increased to $42.7M, but margin declined to 16.8% from 27.7%. Cash ended at $106.8M against $293M of long-term debt. Q4 guidance is $250M–$265M revenue and $45M–$48M adjusted EBITDA, excluding pending acquisitions.
Jushi grows wholesale, while Virginia expansion keeps financing in focus. Q3 revenue increased 7% to $70.5M, including 40% wholesale growth to $9.7M. Adjusted EBITDA reached $13.6M vs. $12.8M, while net loss narrowed to ($12.5M) from ($23.7M). Operating cash flow declined to $3.5M from $6.1M. Cash totaled $30.9M against $215.6M of gross debt subject to scheduled repayment, excluding leases and certain other obligations. Management is exploring financing for Virginia cultivation and processing projects ahead of the scheduled July 2027 adult-use launch.
Glass House increases volume, but sequential profitability falls sharply. Q3 revenue reached $56.8M vs. $47.0M in Q2 and $26.2M a year earlier. Adjusted EBITDA fell sequentially to $0.8M from $5.7M as gross margin declined to 26% from 34%; operating cash flow was ($0.1M). Production reached ~319,000 equivalent dry pounds at $109/pound.
Ascend returns to revenue growth; its free-cash-flow definition excludes new stores. Q3 revenue increased 4.2% to $130.0M, with $31.1M adjusted EBITDA—essentially flat YoY—and a 23.9% margin. Operating cash flow was $5.4M after a $19.1M semiannual interest payment. Reported free cash flow of $2.7M excludes $2.1M of new-store builds. Cash was $63.6M. The 61-store release-date footprint includes partner-owned locations.
MariMed’s record sales do not erase year-over-year EBITDA pressure. Q3 revenue rose approximately 8.5% to US$44.2M. Adjusted EBITDA improved sequentially to US$4.7M but declined from US$5.1M a year earlier, and net loss widened to US$3.5M from US$2.9M. Cash ended at US$10.4M. The operating story is growth in retail and wholesale against continued price pressure—not an across-the-board improvement in profitability.
Planet 13 approaches EBITDA breakeven ahead of the Vireo vote. Q3 revenue was $23.1M, down 0.8% YoY but up 1.0% sequentially. Florida revenue increased 45% YoY, offsetting pressure in Nevada and the California exit. Adjusted EBITDA loss narrowed to $0.2M from $4.1M, while net loss was ($6.4M). Shareholders are scheduled to vote December 10 on the proposed Vireo merger.
Grown Rogue expands into new markets while reporting an acquisition-related loss. Q3 revenue rose 29% to $11.0M, or 25% excluding Michigan wholesale excise tax included in revenue. Adjusted EBITDA increased to $2.6M from $1.5M; net loss was ($8.9M), including a $5M Rogue EBC acquisition loss. Cash rose to $16.6M partly because of consolidating its New York subsidiary. Guidance remains $55M–$63M revenue and $14M–$18M adjusted EBITDA for 2027, excluding New York.
RYTHM’s beverage growth is real—but the legal shelf is at risk. Q3 continuing revenue reached $23.9M; hemp-derived revenue rose 15% sequentially to $6.4M. Beverage depletions annualized to ~320,000 24-can cases across ~8,000 doors.
LEEF Brands x Headwaters Strategic Partnership to Expand into California Flower Market. The partnership begins in November 2026, with expanded cultivation and commercial activity planned for 2027. Under the agreement, LEEF will leverage its large-scale, low-cost cultivation operations at Salisbury Canyon Ranch to produce flower for distribution through Headwaters’ established network. Headwaters will also add LEEF concentrates to its product portfolio, providing both companies with access to new customers and complementary product categories.

Kiva Sales & Service and Petalfast launch Waveform following their merger. Waveform Sales & Logistics is the combined distributor’s new identity following the August 17 transaction closing. Waveform represents 48 brands, serves 975 active stores and handles ~30,000 retail deliveries annually. The company offers three service tiers supported by a digital marketplace, shared customer-management system and inside-sales team.
Arcana Collective Expands PAC Program With 2 New Breeder Partnerships. Arcana Collective, the pioneering collaboration of legacy cannabis breeders and industry leaders, expanded its PAC Program with two new breeder partnerships. The latest additions bring William Wallace Green, the founder of Brave Hearts, and Jackson, aka “Mean Gene from Mendocino,” into Arcana’s growing network of collaborators, further strengthening the company’s commitment to showcasing special breeders and broadening the availability of exceptional new cultivars to market.
🏬 Retail
Stellar expands from the Hudson Valley into Queens. The storefront sits along Hempstead Avenue near the Queens–Nassau County border. Regional reference points include UBS Arena, home of the New York Islanders, Belmont Park Racetrack and Belmont Park Village.
Speakeasy adds Maysville to Kentucky’s medical rollout. The location extends medical-cannabis access in Mason County and northern Kentucky.
GTI opens RISE Mulberry, Its 27th Florida store.
Verano adds its 88th Florida dispensary in Daytona Beach. The MÜV opening brings Verano’s reported national footprint to 165 dispensaries. Verano adds its 87th Florida location in Fernandina Beach. This brings its reported national footprint to 164 dispensaries. It is the second MÜV in Nassau County.
🌱 Product
Cresco enters oral pouches and single-serve THC drink mixes. High Supply SLIPS launches in citrus and wintergreen, with 4mg and 10mg THC options. Wonder drink-mix packets contain 5mg THC. Both initially launched exclusively at Sunnyside dispensaries in Illinois, with broader statewide distribution planned.
Headset Adds Menu Presence to Insights, Giving Cannabis Brands Greater Visibility Into Retail Distribution, Pricing. Brands have traditionally relied on separate sources to track sales performance and retail distribution. Sales data shows what consumers are buying, while online menus show which products retailers carry and how they’re priced. With Menu Presence, Headset Insights brings that information together, making it easier for brands to identify distribution gaps, evaluate pricing and find opportunities for growth.
🧔 People
Sweet Flower workers authorize an unfair-labor-practice strike. UFCW Local 770 members voted to authorize their bargaining committee to call a strike amid contract negotiations. The bargaining committee says that over the last four months of bargaining, Sweet Flower has been canceling scheduled negotiations, failing to present a contract proposal until more than six months after the previous contract expired, and using the delays it caused to avoid paying retroactive wage increases.
🎙️ Interviews
High Spirits — Hirsh Jain on the post-election cannabis map. Jain examines state reform prospects, the Massachusetts repeal result and hemp-beverage risk. Pennsylvania, Wisconsin and Texas feature in the discussion; favorable election outcomes do not remove legislative, licensing or implementation hurdles.
This Week in Cannabis Live — Market, Mavericks, Mayhem. Federal registration roadblocks, public-market access, consolidation and competing Washington priorities.
Trade To Black — MariMed’s Jon Levine and Ryan Crandall on brands, New York and M&A. The CEO and Chief Commercial Officer discuss the record-sales quarter, loyalty, and a potential New York entry through wholesale and licensing rather than owned stores. Levine expresses openness to the right merger partner while resisting an unattractive sale price.



